Feeling something after treatment can be unsettling
After a skin booster, if you feel uneven or raised spots under the skin, worry often comes first. It is hard to tell whether this is expected or a problem that needs attention.
Fortunately, the distinction is relatively simple. Two questions matter most: when it appeared and how it is changing. Embossing right after injection is the mark of material that was placed; it tends to settle over time. A nodule more often appears later and persists or grows. Cellinique Clinic — a 10-minute walk from Apgujeong Station, at 228 Dosan-daero — summarizes how we separate the two in practice.
3-line summary
1. The distinction rests on two factors: when it appeared and the direction of change. Embossing tends to appear right away and settle; nodules tend to appear later and persist.
2. Start judgment from the 1–2 week mark after swelling has eased. Drawing conclusions from early palpation alone is premature.
3. If pain, heat, or redness worsens together, contact the clinic regardless of how you label the finding.
1. Place the two side by side
| Point | Embossing | Nodule |
|---|---|---|
| When it appears | Immediately after injection | Often days to weeks later |
| Shape / pattern | Regular, following injection sites | Tends to stay limited to specific spots |
| Direction of change | Settles over time | Persists or enlarges |
| Accompanying symptoms | Usually none | May or may not be present |
| What to do | Observe for the period you were given | Contact and have it checked |
Row 3 of the table is the practical fork in the road. Check the same spot every few days and see whether the finding is trending smaller or not — that alone usually separates the two.
It also helps to write one short note each time you check: date, which side of the face, approximate size by feel (for example "rice-grain" or "half a pea"), and whether it is tender. When those four fields stay consistent, the direction of change becomes easier to describe in consultation than a vague "it still feels weird."
2. When should you start judging?
The most common mistake is judging too early. Right after treatment, swelling and injection marks are mixed together, so it is hard to know which is which.
| Window | What you see | Judgment |
|---|---|---|
| Same day to a few days | Swelling + injection marks | Too early to label |
| 1–2 weeks | Surface after swelling has eased | Early judgment window |
| After that | Anything newly palpable | Follow the observation period you were given |
That is why, in consultation, you should always ask "Until when should I watch this?" You need a clear end of the observation window so that changes inside that window can be reported on time.
If your calendar has photos, travel, or a major event, share those dates when you ask about the window. The goal is not to force a faster label; it is to know which days still count as expected settling and which days should prompt a call if something new appears or something known begins to grow.
3. Patterns differ by ingredient
Fact check — evidence level: academic overview · single case report
Injectable skin boosters used for aging-skin care differ by type in mechanism and clinical use; these differences have been reviewed in overview literature. There is also a single case report of a nodule in the under-eye (tear-trough) area in the literature.
A case report is a signal that area-specific caution may be needed — not an incidence rate. Different ingredient families can show different reaction patterns, so do not copy one product's information onto another product. (Sources: PMC11560330, PubMed 39283001)
Rejuran is PN, Juvelook is PLA+HA, Profhilo is HA, and GOURI is in the PCL family. You need to know which product you received to explain the course properly, so keep a record of the product name after treatment. Ingredient-level differences are summarized in our skin-booster types guide.
Why timing can differ by ingredient
Each ingredient family works differently inside the skin, so the period you need to observe also differs. Without that context, the bare fact that "something is still there" can create unnecessary worry.
| Family | Examples | What to note in observation |
|---|---|---|
| PN | Rejuran | Early focus on injection marks |
| HA | Profhilo | Separate early volume feel from other findings |
| PLA+HA | Juvelook | Also check changes that appear after more time |
| PCL | GOURI | Follow the observation period you were given |
The table shows general observation directions; specific timelines depend on the product and plan. Use the period given by the clinic where you were treated as your baseline. Applying another product's review timelines to yourself blurs judgment.
If two products were discussed in one visit, keep separate notes for each ingredient family rather than one shared "recovery diary." Online comments often mix brands; your own record should not.
4. Area matters too
In thin-skin areas such as under the eyes, the same finding is easier to feel and easier to see. So "I can feel something" without area detail is hard to interpret on its own.
When you contact the clinic, pass along four items together: which area, since when, roughly what size, and the direction of change. If possible, keep photos in natural light every few days — that makes the direction of change much easier to explain. More detail on Juvelook is in our Juvelook nodule guide.
Thin zones can also look different under office lighting, phone flash, or video calls. If a mark is only obvious in one lighting setup, say so — lighting alone is not a diagnosis, but it is useful context next to the four items above.
5. Contact signals that apply regardless of the label
Fact check — evidence level: regulatory guidance document
In its dermal filler consumer information, the U.S. FDA lists unusual pain during or right after treatment, vision changes, and skin that turns white, gray, or bluish around the injection site as signals that need immediate medical help.
These criteria apply to fillers as addressed by the U.S. FDA; other injectable materials should be checked against each product's own materials. (Source: FDA, dermal fillers)
Some situations call for contact before you decide whether the finding is embossing or a nodule: pain that keeps getting worse over time, heat or redness that spreads, or discharge or blistering. In those cases, verification comes before labeling.
Save the daytime contact path and any after-hours route you were given. When a change appears in the evening, you should not have to re-search the website for how to reach the clinic. Write the route next to the observation window so the plan is usable when you need it.
6. How to keep a record
Describing a course in words is harder than it sounds. Photos and short notes make consultation far more precise.
Take photos in natural light, from the same angle, every few days. Those three conditions are what make comparison possible. If lighting or angle changes, you cannot tell real change from a shooting-condition difference.
For notes, four fields are enough: date, area, size by feel, and whether there is pain. Something like "left under-eye, rice-grain size, not painful" is already usable for judgment. With that record, you can answer "since when and how has it changed?" immediately.
Store photos in one album labeled with the product name and session date. When you return for follow-up, you can scroll the sequence rather than trying to reconstruct memory under time pressure.
7. What to lock in before treatment
To avoid making this judgment alone after the session, there are three items to secure in advance.
How long embossing may remain visible, which changes should trigger contact, and until when you should keep observing. If those three only passed verbally, ask for them in writing. General observation points are on our treatment safety page.
Also confirm how the clinic wants you to send photos or notes (messaging channel, email, or in-person only). A clear channel reduces delay when the change is subtle and you are unsure whether it is worth a call.
8. Consultation and follow-up checklist
□ Did you record the product name and ingredient family
□ Did you hear how long embossing may remain visible
□ Did you agree to start judgment from the 1–2 week mark
□ Are you checking the same area every few days
□ Are you keeping natural-light photos to track the direction of change
□ Did you record which area is involved
□ Did you receive contact criteria and the end of the observation window in writing
□ Do you know to contact promptly if pain, heat, or redness worsens
Bring this checklist on paper or on your phone. Any empty box is a reason to ask again before you leave — not something to "figure out later from reviews."
Frequently asked questions
Q1. Is it normal to feel something right after treatment?
Right after injection, the marks where material was placed can be palpable; these are commonly called embossing. They tend to settle over time. How long they may remain visible varies by product and area, so ask for guidance before treatment.
Q2. How do I tell embossing from a nodule?
Use when it appeared and the direction of change. If it appears right away and shrinks, it leans toward embossing; if it appears later and persists or grows, it needs to be checked. Looking at the same spot every few days usually reveals the direction.
Q3. When should I start judging?
The early judgment window is from the 1–2 week mark after swelling has eased. Before that, swelling and injection marks are mixed and hard to separate.
Q4. Why does the under-eye area feel especially easy to notice?
Under-eye skin is thin, so the same finding is easier to feel and easier to see. That is why you should always pass along area information together for an accurate assessment. Case reports of nodules in the under-eye area also exist in the literature.
Q5. When should I contact the clinic?
Even if the label is unclear, contact promptly if pain is getting worse, if heat or redness spreads, or if discharge or blistering appears. Otherwise, watch the direction of change within the observation period you were given and contact based on that.
Q6. What should I record?
Take photos in natural light, from the same angle, every few days. For notes, date · area · size by feel · pain yes/no — four fields — are enough. That record lets you answer how the finding has changed since it started, which makes consultation more accurate.
Q7. Can I use another person's review timeline as a guide?
If ingredient family, area, and volume differ, observation periods differ too. Use the period given by the clinic where you were treated as your baseline. Applying another product's reviews to yourself blurs judgment.
Consultation information
Cellinique Clinic is at Yeonseung Building, 228 Dosan-daero, Gangnam-gu, Seoul — about a 10-minute walk from Apgujeong Station or Hakdong Station. Medical Director Dr. Kim Gun-woo handles consultation, treatment, and aftercare directly. Course checks and follow-up are arranged individually through consultation.
This article is general information and does not replace medical care. Diagnosis and plans suited to your condition should be confirmed in consultation.
Sources
- Dermal fillers (soft tissue fillers)U.S. Food and Drug Administration
- Juvelook volume under-eye nodule: single case reportPubMed / U.S. National Library of Medicine
- Current overview of injectable skin boosters for aging skin improvementPMC / U.S. National Library of Medicine
Discuss options for your current needs
We review your current health and prior procedures before explaining appropriate options and their limits.



